Full Paper
platinum wire auxiliary electrode, and silver wire reference elec-
trode were used.
123.3, 120.9, 119.6, 37.0 ppm. HRMS: m/z calcd: 556.2145 [M*]+;
found: 556.2153; m/z calcd 557.2224 [M+H]+; found: 557.2238.
Compound 6: Anhydrous dimethylformamide (1.20 mL) and POCl3
(1.5 mL) were added at 08C to a solution of 4 (0.40 g, 0.60 mmol)
dissolved in anhydrous 1,2-dichloroethane (10 mL). The mixture
was heated to reflux for 15 h under a nitrogen atmosphere and
then cooled to RT and neutralized with a saturated solution of
NaHCO3. The crude product was extracted with dichloromethane
and purified by SiO2 column chromatography (ethyl acetate/
hexane, 1:9). The titled compound (370 mg, 85%) was isolated as
Preparation of thin films and encapsulation
Thin films were prepared by drop-casting dichloromethane solu-
tions of the fluorophores onto glass microscope slides. The thick-
ness of the as-cast film of 2 was 40 nm. Encapsulation of the azo-
methine in a PMMA matrix (Mn =70 000 gmolꢀ1) was performed by
dissolving the fluorophore and PMMA in 1:10, 1:30, 1:50, 1:80, and
1:100 weight ratios in dichloromethane. The solutions were drop-
cast onto glass slides. The thin films deposited had thicknesses of
200 nm (1:10), 150 nm (1:30), 160 nm (1:50), 400 nm (1:80) and
230 nm (1:100).
1
a yellow solid. H NMR (400 MHz, [D6]acetone): d=9.84 (s, 2H), 7.82
(d, J=8.1 Hz, 2H), 7.77–7.72 (d, J=8.8 Hz, 4H), 7.45–7.38 (m, 4H),
7.34 (d, J=1.9 Hz, 2H), 7.25 (dt, J=13.9, 4.3 Hz, 6H), 7.16 (dd, J=
8.1, 2.0 Hz, 2H), 7.05 (d, J=8.7 Hz, 4H), 2.05–1.92 (m, 4H), 1.17–
1.07 (m, 12H), 0.81 (t, J=7.1 Hz, 6H), 0.74–0.72 ppm (m, 4H);
13C NMR (100 MHz, [D6]acetone): d=190.8, 154.4, 153.8, 147.5,
146.5, 139.1, 132.0, 130.9, 130.6, 127.1, 126.7, 126.2, 122.5, 122.0,
120.1, 56.4, 40.7, 32.4, 29.8, 24.8, 23.3, 14.5 ppm; HRMS: m/z calcd:
725.4102 [M+H]+; found: 725.4092.
Synthesis
Compound 3: Diphenylamine (1.30 g, 7.7 mmol), CsCO3 (1.54 g,
8.00 mmol), Pd(OAc)2 (70 mg, 0.31 mmol), and tBu3P (62 mg,
0.31 mmol) were added to a solution of 2,7-dibromo-9H-fluorene
(1.00 g, 3.08 mmol) in anhydrous toluene (20 mL). The mixture was
heated under a nitrogen atmosphere at 1208C for 24 h. After cool-
ing, the solvent was evaporated under reduced pressure and the
resulting residue was solubilized in CH2Cl2 and extracted with
water and brine. The organic layer was dried over MgSO4, filtered,
and then concentrated. The crude product was purified by column
chromatography on silica gel (hexane/CH2Cl2, 9:1) to afford the
title compound (1.22 g, 79%) as a pale-brown solid. 1H NMR
(400 MHz, CDCl3): d=7.55 (d, J=8.2 Hz, 2H), 7.26–7.21 (m, 10H),
7.11 (d, J=7.8 Hz, 10H), 6.99 (t, J=7.3 Hz, 4H), 3.72 ppm (s, 2H);
13C NMR (100 MHz, CDCl3): d=148.2, 146.4, 144.7, 136.9, 129.3,
124.0, 123.9, 122.6, 121.6, 120.1, 36.9 ppm. HRMS: m/z calcd:
500.2247 [M*]+; found: 500.2258; m/z calcd: 501.2325 [M+H]+;
found: 501.2337.
Compound 1: A catalytic amount of TFA that was diluted in EtOH
was added to a solution of 5 (100.7 mg, 0.18 mmol) and 7
(93.4 mg, 0.36 mmol) in anhydrous ethanol (10 mL). The reaction
mixture was then heated at 808C for 15 h, then the TFA was neu-
tralized by adding a small amount of Et3N and the solvent was
evaporated. The crude product was purified by SiO2 column chro-
matography (ethyl acetate/hexane, 4:6 with 1% Et3N). The title
1
compound (150 mg, 80%) was isolated as a dark-red solid. H NMR
(400 MHz, CDCl3): d=7.83 (s, 2H), 7.57 (d, J=8.2 Hz, 2H), 7.53 (d,
J=8.8 Hz, 4H), 7.26–7.20 (m, 6H), 7.11–7.02 (m, 8H), 6.97 (d, J=
8.8 Hz, 4H), 6.24 (s, 4H), 4.33 (q, J=7.1 Hz, 4H), 4.19 (q, J=7.1 Hz,
4H), 3.70 (s, 2H), 1.34 (t, J=7.1 Hz, 6H), 1.25 ppm (t, J=7.1 Hz,
6H); 13C NMR (100 MHz, CDCl3): d=164.0, 163.1, 159.5, 150.6,
149.5, 146.1, 144.6, 144.2, 136.8, 132.7, 128.6, 128.4, 128.3, 125.3,
124.4, 123.8, 123.2, 121.5, 120.0, 119.6, 100.5, 59.6, 58.6, 35.6, 12.9,
12.8 ppm; HRMS: m/z calcd: 1037.3361 [M+H]+; found:
1037.3337.
Compound 4: Diphenylamine (1.03 g, 6.1 mmol), CsCO3 (1.22 g,
6.32 mmol), Pd(OAc)2 (55 mg, 0.24 mmol), and tBu3P (50 mg,
0.25 mmol) were added to a solution of 2,7-dibromo-9,9-dihexyl-
9H-fluorene (1.20 g, 2.44 mmol) in anhydrous toluene (20 mL). The
mixture was heated under a nitrogen atmosphere at 1208C for
24 h. After cooling, the solvent was evaporated under reduced
pressure and the residue was solubilized in CH2Cl2 and extracted
with water and brine. The organic layer was dried over MgSO4, fil-
tered, and then concentrated. The crude product was purified by
column chromatography on silica gel (hexane/CH2Cl2, 10:1) and
the title compound (1.31 g, 80%) was isolated as a white solid.
1H NMR (400 MHz, [D6]acetone): d=7.64 (d, J=8.2 Hz, 2H), 7.31–
7.25 (m, 8H), 7.15 (d, J=1.9 Hz, 2H), 7.10–7.07 (m, 8H), 7.04–6.98
(m, 6H), 1.89–1.81 (m, 4H), 1.18–1.07 (m, 12H), 0.81 (t, J=7.2 Hz,
6H), 0.75–0.70 ppm (m, 4H); 13C NMR (100 MHz, [D6]acetone): d=
152.9, 148.9, 147.6, 137.4, 130.1, 124.6, 124.4, 123.4, 120.9, 120.4,
55.8, 40.8, 32.3, 24.6, 23.2, 14.3 ppm. HRMS: m/z calcd: 669.4203
[M+H]+; found 669.4206.
Compound 2: A catalytic amount of TFA that was previously dilut-
ed in EtOH was added to the solution of 6 (163.4 mg, 0.22 mmol)
and 7 (116.4 mg, 0.45 mmol) in anhydrous ethanol (10 mL). The re-
action mixture was heated at 808C for 15 h, then the TFA was neu-
tralized by adding a small amount of Et3N and the solvent was
evaporated. The crude product was purified by SiO2 column chro-
matography (ethyl acetate/hexane, 4:7 with 1% Et3N) to afford the
title compound (165 mg, 61%) as
a
dark-red solid. 1H NMR
(400 MHz, CDCl3): d=7.90 (s, 2H), 7.59 (d, J=8.8 Hz, 4H), 7.53 (d,
J=8.1 Hz, 2H), 7.33–7.27 (m, 4H), 7.15 (d, J=7.6 Hz, 4H), 7.11–7.02
(m, 10H), 6.26 (s, 4H), 4.38 (q, J=7.1 Hz, 4H), 4.25 (q, J=7.1 Hz,
4H), 1.83–1.73 (m, 4H), 1.40 (t, J=7.1 Hz, 6H), 1.31 (t, J=7.1 Hz,
6H), 1.18–1.01 (m, 12H), 0.81 (t, J=7.2 Hz, 6H), 0.67 ppm (m, 4H);
13C NMR (100 MHz, CDCl3): d=165.8, 164.7, 159.2, 152.7, 152.5,
150.6, 147.2, 145.8, 137.2, 135.4, 129.8, 129.6, 129.0, 128.3, 125.2,
124.8, 124.0, 121.5, 120.4, 120.3, 103.2, 61.5, 60.4, 55.3, 40.2, 31.7,
29.6, 23.9, 22.6, 14.5, 14.3, 14.2 ppm; HRMS: m/z calcd: 1205.5239
[M+H]+; found: 1205.5237.
Compound 5: Anhydrous dimethylformamide (2.3 mL) and POCl3
(2.9 mL) were added at 08C to a solution of 3 (0.6 g, 1.2 mmol) dis-
solved in anhydrous 1,2-dichloroethane (5 mL). The mixture was
heated to reflux for 15 h under a nitrogen atmosphere and then
cooled to RT and neutralized with a saturated solution of NaHCO3.
The crude product was extracted with dichloromethane and puri-
fied by SiO2 column chromatography (dichloromethane/hexane,
8:2). The title compound (530 mg, 81%) was isolated as a yellow
Single-crystal structure determination
X-ray diffraction data (Table 4) were collected with a Bruker APEX-II
CCD diffractometer with GaKa radiation (l=1.34139 ꢃ). The crystal
was kept at 100 K during data collection. Using Olex2,[28] the struc-
ture was solved with the XT[29] structure solution program using
direct methods and refined with the XL[30] refinement package
using least-squares minimization. CCDC 1454905 contains the sup-
1
solid. H NMR (400 MHz, CDCl3): d=9.82 (s, 2H), 7.72–7.66 (m, 6H),
7.38–7.32 (m, 6H), 7.23–7.15 (m, 8H), 7.03 (d, J=8.7 Hz, 4H),
3.82 ppm (s, 2H); 13C NMR (100 MHz, CDCl3): d=190.6, 153.60,
146.4, 145.2, 145.1, 138.5, 131.5, 129.9, 129.3, 126.3, 125.6, 125.2,
&
&
Chem. Eur. J. 2016, 22, 1 – 13
10
ꢂ 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
ÝÝ These are not the final page numbers!